GMO Emerging Markets R6
Not enough financial coverage to compute a composite score for GEMNX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.gmo.com/asia/investment-capabilities
Under normal circumstances, the fund invests at least 80% of the fund’s net assets directly and indirectly (e. g. , through underlying funds or derivatives) in companies tied economically to markets that are not treated as “developed markets in the MSCI World Index (“emerging markets”).
- IPO
- 2020
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $522.86M
- Div Yield
- 3.95%
Performance & Tape
- 52W High
- $39.90
- 52W Low
- $25.30
- 50D MA
- $33.93
- 200D MA
- $31.24
- Beta
- 0.97
- Avg Volume
- 0
Get TickerSpark's AI analysis on GEMNX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GEMNX Coverage
We haven't published any research on GEMNX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GEMNX Report →